Chemoinformaics analysis of Methyl 4-vinylbenzoate
| Molecular Weight | 162.188 | nRot | 2 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 8 |
| Exact Molecular Weight | 162.068 | nRing | 1 |
| Solubility: LogS | -3.513 | nHRing | 0 |
| Solubility: LogP | 2.848 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.9719 |
| nHD | 0 | BPOL | 12.6361 |
| QED | 0.622 |
| Synth | 1.668 |
| Natural Product Likeliness | 0.034 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.464 |
| MDCK | 0.000024 |
| BBB | 0.667 |
| PPB | 0.880429 |
| VDSS | 0.981 |
| FU | 0.0824919 |
| CYP1A2-inh | 0.969 |
| CYP1A2-sub | 0.617 |
| CYP2c19-inh | 0.383 |
| CYP2c19-sub | 0.44 |
| CYP2c9-inh | 0.292 |
| CYP2c9-sub | 0.748 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.608 |
| CYP3a4-inh | 0.037 |
| CYP3a4-sub | 0.25 |
| CL | 10.657 |
| T12 | 0.782 |
| hERG | 0.07 |
| Ames | 0.017 |
| ROA | 0.046 |
| SkinSen | 0.686 |
| Carcinogencity | 0.717 |
| EI | 0.984 |
| Respiratory | 0.163 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.877079 |